No Data
No Data
No Data
No Data
No Data
Opyl Ltd Announces Director's Final Interests
TipRanksMay 2 10:17
Opyl Ltd. Advances AI Platform and Streamlines Business
TipRanksApr 30 13:08
Opyl Ltd. Calls for Virtual General Meeting
TipRanksApr 29 11:57
Opyl Expands TrialKey Coverage; Shares Up 38%
Digital health company Opyl (ASX:OPL) expanded its TrialKey.ai platform, increasing its coverage to 350,000 trials from 65,000 and enhancing its ability to predict and optimize clinical research and d
MT NewswiresApr 29 09:40
Opyl to Divest Opin Business
Opyl (ASX:OPL) signed a binding sale and purchase agreement to divest its Opin business, allowing the company to focus on high-growth, artificial intelligence-related ventures, according to a Tuesday
MT NewswiresApr 23 10:36
Opyl Divests Subsidiary Opin to Focus on Development of AI Clinical Trial Platform
Opyl (ASX: OPL) will divest its clinical trial recruitment subsidiary Opin to an entity controlled by global health technology entrepreneur Dr Hugo Stephenson.
Small CapsApr 23 09:51
No Data
No Data